Stockreport

Gilead Sciences: Remdesivir Remains A Distraction [Seeking Alpha]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF SummaryGilead Sciences remains too focused on Remdesivir as a treatment for COVID-19 despite no expected long-term benefit.The biopharma faces demand hits to key HIV and [Read more]